bone marrow transplantation an issue of hematology
phoblastic Leukemia (ALL): Particularly in relapsed or refractory cases. Chronic Myeloid Leukemia (CML): Historically, less common now due to targeted therapies, but still relevant for advanced or resistant cases. Multiple Myeloma: Autologous BMT is standard for eligible patients. Lymp